drugset
drugset / Trial / NCT01135602

Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study

NCT01135602 ↗

Phase 4 Unknown 150 enrolled Chiang Mai University
NaSingle-groupOpen-labelTreatment

Summary

12-week, open-label study of topiramate in hospitalized patients with alcoholism

Timeline

Start
2010-07
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg Oral
Subject Topiramate Small molecule 300 mg Oral

Indications

alcohol dependence